Clinical Trials Browser

In Situ Hybridization, Fluorescence × Genitourinary × 1 year × Clear all

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01382706 2025-10-09

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Phase 2 Terminated

15 enrolled 10 charts

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

IT-TCP POS

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder